Two Sigma Advisers
JUNO

Two Sigma Advisers’s Juno Therapeutics, Inc. JUNO Stock Holding History

Two Sigma Advisers’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-33,761
Closed -$1.54M – 2498
2017
Q4 		$1.54M Buy
+33,761
New +$1.68M ﹤0.01% 1355

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Two Sigma Advisers's JUNO Position: Q1 2018 in Review

Two Sigma Advisers sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 33,761 shares — an estimated $1.54M sold.

Two Sigma Advisers first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $1.54M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Two Sigma Advisers reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Two Sigma Advisers sold 33,761 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.54M.
  • Two Sigma Advisers first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
  • Two Sigma Advisers's Juno Therapeutics, Inc. position peaked at $1.54M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Two Sigma Advisers's 13F filing for Q1 2018, filed 15 May 2018.